MedPath

Efficacy of plasma injections, and extracorporeal shock wave therapy, in thetreatment of work –related lateral epicondylitis

Phase 1
Conditions
The epicondylitis is an overuse injury, in most cases, is a self-limited course andresponds well to conservative treatment. Its etiology is degenerative and is relatedto a repetitive overuse and underlying tendinopathy.
Therapeutic area: Diseases [C] - Musculoskeletal Diseases [C05]
Registration Number
EUCTR2018-002650-67-ES
Lead Sponsor
Ibermutuamur (Mutua Colaboradora con la Seguridad Social nº 274)
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Authorised-recruitment may be ongoing or finished
Sex
All
Target Recruitment
66
Inclusion Criteria

- Workers diagnosed with work-related epicondylitis (ICD 9-CM code 726.32) as the primary diagnosis, receiving healthcare in Ibermutuamur. - Age equal or greater than 18 years. - Patients receive this diagnosis after being explored: painful sensitivity to pressure on the epicondyle; Cozen maneuver; chair test; and
radiological examination. - Does not present remission of symptoms after a period of approximately 25 days of conservative treatment that include oral medication, local cold, functional relative rest and rehabilitation.
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 66
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

- Patients with cervical pathology. - With posterior interosseous neuropathy. - With any kind (unless cancer pathology hospital discharge) cancer. - Patients with mental health problems that prevent them from successfully follow rehabilitation treatment. - Patients with thrombocytopenia. - Patients who have pacemakers. - Clotting problems or anticoagulant therapy. - Rheumatoid arthritis diagnosed. - Pregnant or breast-feeding patients. - Treatment with deposit costicoesteroid infiltrations in the last 6 weeks

Study & Design

Study Type
Interventional clinical trial of medicinal product
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath